Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

@article{Goff2007IntravitrealBF,
  title={Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.},
  author={Mitchell J Goff and Robert N Johnson and H. Richard McDonald and Everett Ai and James Michael Jumper and Arthur D. Fu},
  journal={Retina},
  year={2007},
  volume={27 4},
  pages={432-8}
}
PURPOSE To report the optical coherence tomography (OCT) findings and visual results in a series of patients treated with intravitreal bevacizumab for choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD), and to determine if a difference in treatment effect exists between previously treated and treatment naïve patients. METHODS A retrospective review of all patients treated with intravitreal bevacizumab for CNV from AMD with visual acuity greater than or… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…